Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1212"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1465"
rdf:type	?:Evidence ?:Item
?:Evidence_assump_list_id	"209"
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:claim_assumed_valid_for_evidence_application_evidence_1465	?:midazolam_primary_total_clearance_enzyme_cyp3a4
?:content	"Midazolam Concomitant administration of telithromycin with intravenous or oral midazolam resulted in 2- and 6-fold increases, respectively, in the AUC of midazolam due to inhibition of CYP 3A4-dependent metabolism of midazolam."
dc:creator	"boycer"
dc:date	"01/11/2010 15:43:44"
rdfs:seeAlso	?:4471223e-9023-457e-be2e-8e4e0c2d94d1

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ telithromycin_inhibits_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1465 }

Context graph